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Purpose: The purpose of this paper is to describe the application of soft systems methodology 
(SSM) to address the problematic situation of low opt-in rates for Precision Health-Care (PHC). 
Design/methodology/approach: The design logic is that when trust is enhanced and compliance 
is better assured, participants such as patients and their doctors would be more likely to share 
their medical data and diagnosis for the purpose of precision modeling. Findings: The authors 
present the findings of an empirical study that confronts the design challenge of increasing 
participant opt-in to a PHC repository of Electronic Medical Records and genetic sequencing. 
Guided by SSM, the authors formulate design rules for the establishment of a trust-less platform 
for PHC which incorporates key principles of transparency, traceability and immutability. 
Research limitations/implications: The SSM approach has been criticized for its lack of 
“rigour” and “replicability”. This is a fallacy in understanding its purpose – theory exploration 
rather than theory confirmation. Moreover, it is unlikely that quantitative modeling yields any 
clearer an understanding of complex, socio-technical systems. Practical implications: The 
application of Blockchain, a platform for distributed ledgers, and associated technologies present 
a feasible approach for resolving the problematic situation of low opt-in rates. Social 
implications: A consequence of low participation is the weak recall and precision of descriptive, 
predictive and prescriptive analytic models. Factors such as cyber-crime, data violation and the 
potential for misuse of genetic and medical records have led to a lack of trust from key 
stakeholders – accessors, participants, miners and regulators – to varying degrees. 
Originality/value: The application of Blockchain as a trust-enabling platform in the domain of 
an emerging eco-system such as precision health is novel and pioneering. 
 




1. Challenges facing Precision Health-Care 
 
An emerging trend in the practice of medicine known as Precision Health-Care (PHC) has been 
suggested as a promising service on digital health ecosystems or clouds. It is defined as the 
development of a quantitative model which links the individual EHRs to the population and 
derives the benefit of aggregating EHRs with consideration to social context (Colijn et al., 
2017). Although there are distinctions made between PHC and personalized medicine, a 
simplifying assumption is that the former is a system-level perspective whereas the latter is 
patient-centric. More specifically, PHC comprises health and medical records which are 
networked to various front-end clients. It is an instance of an evidence-based approach which 
provides personalized medicine, including clinical decisions, treatments and products to the 
individual patient (Lu et al., 2014; Zimmerman, 2019). This approach is driven by data analytic 
models, which possess the ability of dealing with large amounts of genome information which 
combine genetic diagnoses with EHRs or EMRs (Mehta and Pandit, 2018). 
 
With the support of robust data analytics and machine learning, PHC is capable of descriptive, 
predictive or prescriptive diagnostics by benchmarking individuals with the population in order 
to “discover” diseases, treatments or outcomes (Colijn et al., 2017). Typically, patients of 
universal healthcare who opt-in, consent to share their medical data (including genetic sequence 
data) into such a data base. They are the actual cases used for the construction of regression or 
machine learning models, which formulate prescriptions and predictions linking to diagnosis, 
treatments and outcomes with anonymised patient profiles as moderators. When PHC is applied 
as a service, input will be the patient’s profile and diagnosis report(s); and the output will be the 
treatment (e.g. therapy, medication, behavioural changes and surgical procedure). In a best-case 
scenario, PHC learns from each health event of individuals who opt-in and provides more precise 
predictions along with prescriptions. However, the reluctance of individuals to opt-in and share 
genetic and medical data results in a weaker analytic model and machine learning environment 
and hence a tragedy-of-the-commons scenario for PHC. 
 
With Digital Healthcare having “crossed the chasm”, a large volume, velocity, variety and 
veracity of health data is produced and shared among numerous players in the eco-system such 
as Patients (Consumers), (Health-Care) Providers, Payers, Vendors, Infomediaries and 
Regulators (Stephanie and Sharma, 2016). The twin issues of security and privacy are hence 
critical. Security refers to protection against the unauthorized access or modification of health 
data such as controls in place to limit who can access the information. Privacy is harder to 
define, in part because user-specific details (Personally Identifiable Information (PII)), 
preferences and contexts, but also because it refers to what many believe to be a “human right”. 
The idea of what constitutes PII is an important aspect of security and privacy in digital health 
and contribute significantly to user experience[1]. 
 
Cyber-security in health-care is a major problem with “hundreds” of reported violations 
(Williams, 2019). In reality, most people are unwilling to share their health data, considering that 
such disclosure might negatively impact on their privacy (Patil and Seshadri, 2014). An intrusive 
aspect of PHC is the requirement for genetic sequencing information from patients. Research 
by Ponemon (2016) suggests that 38 per cent are not willing to participate in genetic testing 
because of deep-rooted distrust. In current PHC platforms, patients’ privilege and control over 
their medical data are limited by insufficient data transparency; patients often do not know or 
control who accesses their health records and for what reason (Colijn et al., 2017). Neither are 
players in the PHC eco-system explicitly accountable for data breaches (Das et al., 2016). The 
Trusted Third Party (TTP) – a service provider – neither has the moral right nor the technical 
ability to mediate. However, unlike conventional EHRs and EMRs, genetic information is not 
common in established clinical practice (Nguyen et al., 2014). For better treatment outcomes, 
sharing of personal health information (e.g. historic medical records of profiles, symptoms, 
treatments and outcomes) with patients’ consent is necessary. Nevertheless, the contribution of 
sensitive genetic information for the development of predictive or prescriptive data models is 
controversial (Lunshof et al., 2008). For reasons discussed by Schatz et al. (2017), among others, 
patients’ high concern with respect to privacy and security of their genetic information 
contributed to their low enthusiasm for opting-in to the “collective good” of PHC (Brothers and 
Rothstein, 2015). 
 
PHC hence gives rise to a “tragedy of the commons” scenario. Large contributions of rich cases 
from patients’ opting-in and sharing their EHRs and EMRs allows the building of robust models 
and gain sufficient samples for data mining (Van Poucke et al., 2016). Through data analysis, 
errors or redundancies in high volume and variety data sets can be reduced, which ensures higher 
accuracy of future outcomes even in complex, multilevel demographics (e.g. age, gender and 
ethnicity). Such collection of data with wider variation enriches the variety of data sources and 
leads toward the development of robust predictive models accordingly (Sedgwick, 2015). The 
availability of gene sequences from patients provides greater analytics ability of PHC (Frey et 
al., 2014). However, while prospective users of PHC may wish to benefit from its advantages, 
they may not wish to risk their own medical records to misuse or abuse. Another significant 
concern of opting-in to a genetic sequence based PHC is that law-enforcement authorities may 
choose to subpoena such records and link patients to any number of activities. There was a need 
to examine the efficacy of a data management technology that protects against such abuses. 
 
The application of Blockchain to digital health has received increasing research attention 
(Brodersen et al., 2016; Burniske et al., 2016; Mackey et al., 2019; Mettler, 2016; Yue et al., 
2016; Halamka et al., 2017; Agbo et al., 2019; Park et al., 2019; Shuaib et al., 2019; Siyal et al., 
2019). Rabah (2017) claims that the technology – particularly its automated verification and trust 
resolution capabilities – promises the safe and interoperable sharing of real-time data among 
stakeholders that is required in a trusted digital health platform. To address the problem of low 
opt-in rates due to a lack of trust in a PHC service, our research objective is to explore the design 
feasibility of a Blockchain-based solution for PHC. The specification of design principles and 
artefacts is derived empirically through the application of Soft Systems Methodology (SSM) – 
developed by Peter Checkland (1995, 2000) and his associates for the purpose of developing 
socio-technical solutions where the interactions of technologies and their human users determine 
implementation success. The remainder of this paper is organized as follows. The next section 
reviews the underlying functionalities of Blockchain and their application to PHC. Following 
this, the paper outlines the major steps of SSM and their adaptation to our field study. Section 
4 describes the application of Blockchain to PHC using SSM in order to address issues of data 
security and privacy. Section 5 is a discussion of the derived design principles that provide a 
solution to the problem of low opt-in rates. The paper concludes with some insights for policy 
and a recap of theoretical, practical and methodological contributions. 
 
2. Background review of health Blockchains 
 
Blockchain is a decentralized, distributed, anonymous, time-stamped ledger of data records 
(Shuaib et al., 2019) which seems to intuitively fit with current digital health environments. 
Blockchains have received scholarly attention for their unique security characteristics such as 
being tamper-proof and transparent (Naerland et al., 2017). Note that whilst a decentralized and 
distributed platform does not provide any security nor privacy guarantees, the unique functional 
attributes of the technology do. For instance, it is possible to exchange data records on such a 
network without the need for a centralized TTP (Agbo et al., 2019) nor a “new clearing house” 
or “safe deposit box”, but an intelligent control of records with a time-stamped, programmable 
ledger (Halamka et al., 2017). Data in blocks form a chain of events, for example, the enrolment 
of a patient with a healthcare provider and her subsequent health transactions. Additions to these 
blocks are allowed if and only if broadcast by authorized entities and any changes are traceable 
(Xia et al., 2017). Moreover, they are also synchronised and immutable; when a change occurs, 
all nodes in the network are notified and typically the change is effected when there is >50 per 
cent consensus (Shuaib et al., 2019). In terms of functionalities, Blockchains go beyond the 
common use-case as crypto-currencies (Underwood, 2016). 
 
Closely associated with Blockchain is the notion of a “Smart Contract” (SC) which is an 
extension of contractual obligations in the digital era. It can be defined as a set of programmable 
codes and privileges which can automatically move digital assets (including information) 
depending on pre-specified rules (Buterin, 2014). Data blocks may be programmed to be 
accessible with various rights (read, write, edit, delete, etc.) by all (public and permission-less) or 
pre-approved (private and permissioned) participants. All such terms of the contract are 
encrypted with Blockchain technology. SC hence alters the traditional notion of trust with an 
open, transparent and non-retractable scheme where the encryption key is now more important 
than trust. The SC codes may be audited to guarantee fairness and compliance (O’Hara, 2017). In 
a “private, permissioned” context such as digital health records, “only pre-defined nodes can 
read, submit and validate transactions” (Naerland et al., 2017). There can also be classes of data 
(or objects) which contain unique read–write–edit–delete (RWED) privileges for various entities 
(e.g. patients, physicians, specialists, hospitals, regulators and payers). Large data sets may also 
be partitioned into centrally stored and distributed-blocks components. Hence, SC is a useful 
mechanism to implement such pre-specified rules, though solutions referring to the practice of 
PHC are few. 
 
A meta-analysis of research reviews was conducted in order to synthesize the functional 
attributes of Blockchain that provide “trustless” security and privacy. Specifically, an electronic 
search of research spanning 2016–2019 using Google Scholar and Research Gate was performed 
using the following keywords and expressions: Review AND Blockchain AND (precision OR 
personalized) AND (health OR medicine). Upon examining the titles and abstracts over a 
hundred hits, a representative set of 15 articles was selected on the basis of their relevance and 
applicability to our objective of investigating the functional attributes of Blockchain in precision 
health. The performance considerations of Blockchain are beyond the scope of this paper and 
research describing such topics excluded from further analysis. 
 
Table I summarizes the scope and coverage of the representative set of recent research articles 
that were selected for our meta-review. On closer examination, three distinct categories of 
coverage could be discerned: i) Blockchain in health, ii) Blockchain implementation and iii) 
PHC. At a high level, the focus of such scholarly reviews was to comprehensively explore issues 
and challenges in the application of Blockchain to Healthcare (cf. Agbo et al., 2019), address 
functional design of Blockchain implementations (cf. Xia et al., 2017) and in category (iii) 
describe the merits or perils of PHC (cf. Love-Koh et al., 2018). Some articles were more 
expansive, covering two categories (cf. Vazirani et al., 2019). To probe further, full text (PDF) 
documents of the 15 references given in Table I were parsed using the Nvivo v12 Qualitative 
Analysis software. Whereas a thematic analysis is not within the scope of this section, detailed 
outputs from Nvivo and brief annotations may be found in the Online Appendix 1 accompanying 
this paper (Electronic or digital copies are available from the corresponding author). 
 
Table I. Meta-review of background research (2016–2019) 
Reference Category Title Extract – quotes 




Systematic Review of 
Blockchain Technology 
in Healthcare 
While a number of studies have proposed different use cases for the 
application of blockchain in healthcare, there is a lack of adequate 
prototypes and studies to characterize the effectiveness of these 
2. Bruynseels 
et al. (2018) 
Precision 
Health 
Digital Twins in Health 
Care: Ethical 
Implications of an 
Emerging Engineering 
Paradigm 
A Digital Twin might not be an accessible technology for everyone, and 
given the fact that patterns identified across a population of Digital Twins 
can lead to segmentation and discrimination. This duality calls for 
governance as this emerging technology matures, including measures that 









in Piloting Blockchain 
Awareness and understanding of the technology, capacity constraints of in-
house support services and issues related to engaging in non-traditional 
partnerships. Three types of precision medicine are expected to emerge in 
clinical practice: complex algorithms, digital health applications and 
“omics”-based tests 




From genomes to 
genomic medicine: 
enabling personalized 
and precision medicine 
in the Middle East 
Reviews the genome projects and suggests how addressing the key areas 
including education, regulatory and ethical frameworks would accelerate 
Precision Medicine in the Middle East region 
5. Love-Koh 
et al. (2018) 
Precision 
Health 
The Future of Precision 
Medicine: Potential 
Impacts for Health 
Technology Assessment 
Innovation in precision medicine promises substantial benefits but will 
change the way in which some health services are delivered and evaluated 









in the future of 
healthcare 
Blockchain is a shared distributed digital ledger technology that can better 
facilitate data management, provenance and security, and has the potential 
to transform healthcare. However, it’s conceptualization, development and 
deployment must consider actual healthcare needs from the diverse 
perspectives of consumers, patients, providers and regulators 




Concurrence of big data 
analytics and healthcare: 
a systematic review 
There is a paucity of evidence of real-world use of Big Data analytics in 
healthcare because usability studies have only considered qualitative 
approaches, and a majority of the studies were from developed countries 






Review of Challenges 
and Opportunities for 
Blockchain Powered 
Healthcare Systems 
Blockchain is immutable, time-stamped, tamper-proof ledger, accessible by 
all or preapproved participants and hence provides efficiency, security and 
privacy 
Reference Category Title Extract – quotes 




Blockchains for Secure 
Digitized Medicine 
Decentralized, distributed, without the need for a third trusted party (TTP), 
characteristics of blockchains are used to solve issues of cyberattacks could 
benefit healthcare systems and empower personalized medicine 







challenges to address 
vulnerabilities 
Theorem Proving and model checking are the most common formalization 
techniques used to verify security properties 






in Medicine and 
Healthcare: Challenges 
and Future Perspectives 
Blockchain provides personalized, authentic, up-to-date and secure 
healthcare by merging real-time clinical health records 





Systematic Review of 
Implementing 
Blockchains for 
Efficient Health Care 
Blockchain could create a mechanism to manage access to EHRs stored on 
the cloud and increase interoperability while maintaining privacy and 
security of data. It contains inherent integrity and conforms to strict legal 
regulations 




The Patient in Precision 




Precision medicine (PM) has the potential to tailor healthcare to the 
individual patient by using their genetic information to guide treatment 
choices However, this process is complex and difficult to understand for 
patients and providers alike. it is evident that more work must be done to 
ensure that patients can engage in their care when faced with PM 





Sharing for Electronic 
Medical Records in 
Cloud Environments 
Private, permissioned blockchain-based data sharing framework that 
addresses the access control challenges of sensitive cloud data using 
immutability and built-in autonomy properties 






for Modern Healthcare 
Infrastructure 
Potential applications of the blockchain in medicine include interoperable 
health data access, data storage and security, value-based payment 
mechanisms, medical supply chain efficiency, amongst others. While 
nascent, it is essential the healthcare community understand the 
fundamental concepts and potential impact on the future of healthcare 
 
Figure 1 is a word cloud produced by Nvivo using PDF documents of the references listed 
in Table I. In terms of coverage, it is clear that the representative set of review articles have 
focused on topics central to our review. Using a synonymic, term-matching algorithm, Nvivo 
produced the following thematic links across the 15 articles reviewed: “health”, “blockchain”, 
“research”; “technology”, “system”, “process”; “data”, “information” and “process”. This is 
indicative of the scope and representative coverage of the review articles. Although there were 
differences in the clouds produced from the three categories of review articles, they were not 
salient. As our research focus is specifically about the security and privacy functionalities 
inherent in Blockchain, we examined the coverage of “security” and “privacy” in the 15 articles 
by generating word-trees (see Online Appendix 1, electronic or digital copies are available from 
the corresponding author). While not as central as the themes listed above, we may claim face 
and construct validity in that security and privacy were well-linked within the discussions of the 
15 review articles. Primarily, of deepest and most direct interest for this meta-review, we were 
able to derive key Blockchain design attributes and their support in the review literature from the 
Nvivo-generated word trees of security and privacy (Table II). Each of the five attributes – 
transparent, traceable, tamper-proof, immutable and compliant – shall be utilized in the field 
research. Outside the scope of digital health, Zhang et al. (2018) have reported that transparency, 
traceability and immutability are among the fundamental considerations towards more secure 




Figure 1. Word cloud of key terms used in blockchain research 
 
Table II. Deprivation and support for blockchain 3TIC attributes 
Design attribute Brief description Support [as listed in Table I] 
Transparent RWED accesses to data in blockchain are visible to all (public, 
permission-less) or authorized (private, permissioned) users 
[1–15] 
Traceable Logs and audit trails of any RWED access to data in 
blockchain 
[1, 3, 6, 8, 10, 11, 14] 
Tamper-proof Consensus algorithm prohibits any WED changes to data […] 
new data must be approved by consensus 
[6, 8, 12, 14] 
Immutable The bockchain itself (data, links, etc.) is encrypted and cannot 
be edited nor deleted 
[1, 6, 8–12, 14] 
Compliant SC will not execute any transaction that violates agreed data 
protection policies of the blockchain 
[1, 6, 9, 12, 15] 
 
To sum up, there is considerable agreement that Blockchain could bring a technically feasible 
improvement to the outcomes of PHC since it relies on an element of trust, satisfies the “big” 
needs of genomic data and significantly depends on higher opt-in rates of patients. Rabah 
(2017) suggests that the immutable, time-stamped, tamper-proof functionalities of Blockchain 
provides “efficiency, security and privacy” in patient care. However, such a claim has yet to be 
tested in large-scale implementations of PHC. The security and privacy attributes of Blockchain 
could provide considerable value to the health eco-system by providing a trusted environment, 
reducing unnecessary processing and decreasing its cost (Brakeville and Perepa, 2017). But 
again, the “how” question of such a design claim has yet to be addressed. More specifically, how 
can the distributed, decentralized and non-TTP nature of Blockchain address the security and 
privacy considerations of PHC? This remains a fundamental research gap. In Sections 35, the 
SSM approach to exploring such a solution is described. 
 
3. Field research method 
 
PHC ecosystems are complex and involve multiple “clients” (users), “actors” (stakeholders), 
“purposeful activities” (clinical protocols), “work-views” (health outcomes) and “environmental 
constraints” (ethics, policy, legislation, etc.). In such a context, the Soft System Methodology 
(SSM) appears appropriate for action research which helps to clarify ill-defined system 
requirements (Checkland, 1995, 2000; Checkland and Scholes, 1999; Staker, 1999). Over a 30-
year period, it had been applied to hundreds of complex projects including diverse design 
challenges such as the Concorde Aircraft and the National Health Service in the UK. SSM 
originated from “systems thinking” and is an element of research which “concentrates on 
situations in which people are trying to take action” (Checkland, 2000, p. S41). 
 
SSM is suited for investigating “purposeful action to change world views”, namely, how 
Blockchain could enhance trust in a PHC eco-system and hence increase opt-in rates for the good 
of all. A key feature of SSM is the expression of significant requirements through the drawing of 
rich pictures, which follows the stages of the model’s root definition and operating framework 
(Checkland and Scholes, 1999). The resulting artefact is then tested by applying the derived 
solution in a production environment. The model construction was accomplished by conducting 
interviews with key stakeholders to examine whether the proposed Blockchain-based ecosystem 
would address the “problematical situation” of low opt-in levels. Such an approach to field 
research which incorporates “case based reasoning” is well established in the field of health-care 
(cf. Andersen et al., 2019; Laurenza et al., 2018). It is also not inconsistent with the socio-
technical approach (cf. Palvia et al., 2001) which considers a system intervention such as 
technology, in the wider context of the tasks, organizations and stakeholders involved. 
 
Figure 2 shows a “rich picture” of the SSM approach. Overall, SSM consists of four milestones 
(Checkland, 2000) across the seven steps originally identified by Checkland (1995). Descriptions 
of the procedures remain beyond the scope of this paper. In summary, Steps 1 and 2 fulfil the 
first milestone of finding out a “problematical situation” using techniques such as “rich pictures”. 
Steps 3 and 4 fulfil the second milestone of formulating some relevant “purposeful activity” 
models. Step 5 fulfils the milestone of using the models for debate and discussion with the 
objective of achieving feasibility. Steps 6 and 7 fulfil the milestone of taking action to improve 
the situation. It should be noted that the milestones of SSM are consistent with Design Science 
Research (DSR) approach synthesised by Peffers et al. (2007): problem identification and 
motivation, definition of the objectives for a solution, design and development of artefacts, 
demonstrations of prototypes or proofs-of-concept, evaluation against key success criteria and 
communication of the design specifications to stakeholders. The seven steps of SSM may also be 
viewed from the lens of the classic relevance-rigour-design cycles of DSR earlier proposed 
by Hevner et al. (2004). In a retrospective journey, Checkland (2000) acknowledged the holistic 
consistencies between SSM and other offshoots of DSR such as Systems Theory and Design 
Thinking. While the later focus on the development of design artefacts such as UML diagrams, 
prototypes and source codes, SSM primarily addresses the specification of a feasible solution for 
the problem being considered. 
 
 
Figure 2. Using the soft systems methodology for PHC 
 
The problematical situation here is the low “opt-in” of patients to a PHC offering. The design 
challenge is whether a Blockchain-enabled SC would alleviate the hesitancy of stakeholders 
(mainly patients) to share their EHRs including genetic sequencing. Using an SSM approach 
therefore requires addressing some key questions to major stakeholders such as patients, doctors, 
health administrators and policy-makers. A key element of SSM is the design discussion, 
which Checkland (1995) suggests is an effective means of modelling purposeful activities so as 
to discover desirable and feasible changes in system features and requirements (also see 
Libakova, 2015). Compared to large sample methods, the input from such interviews is more 
reliable and valuable as these are obtained from informed and engaged industry professionals 
(Dorussen et al., 2005). It is also effective for comparing a proposed solution (ie Blockchain-
enabled PHC) with the current problematic situation with low opt-in rates in order to extract 
valuable insights for improvement (Littig and Pöchhacker, 2014). 
 
In accordance with the research ethics approval obtained for this study, a detailed “call for 
participation” was sent over e-mail to possible clients and actors who were informed and willing 
to contribute their time and inputs. The e-mail included background information on PHC, 
Blockchain and the design interview template (see Online Appendix 2, electronic or digital 
copies are available from the corresponding author). It is critical to establish that validation of an 
SSM study very much depends on identifying “lead” users and actors who could articulate 
issues, challenges and latent needs in a credible manner (Checkland and Poulter, 2010). Seven 
carefully vetted interviewees across different roles within the healthcare industry (two patients, 
two providers, one District Health Board (DHB) administrator, one PHC vendor and one health 
policy analyst) consented to giving their comments and inputs to the design of the Blockchain-
enabled PHC. In accordance with the systems thinking school of thought, design interviews, 
workshops and focus groups are intense, creative activities which are deliberately kept to a 
certain length of time; quality takes precedence over quantity (Hanafizadeh and Mehrabioun, 
2018). Our design interviews, each lasting up to 2 h, were conducted in a set sequence whereby 
each patient and then each practitioner was interviewed to give a generalist, high level input as 
“clients or customers” of a Blockchain-enabled PHC. As interviews proceeded to involve the 
“actors” – administrator, vendor and analyst, they took an increasingly more PHC-specific focus. 
The use of SSM visual techniques were augmented by UML tools (specifically, activity and use-
case diagrams, cf. UML, 2017) for the purpose of exploring, communicating and clarifying 
design ideas, thoughts and enhancements. 
 
The rich pictures and activity diagrams that were developed as design artefacts were based on a 
use case of New Zealand’s universal-access healthcare ecosystem (Gauld, 2016). Along with a 
brief overview of the scope and objectives of the research and an introduction to Blockchain 
technology, rich pictures served as the starting point to a discussion with interviewees about 
Digital Healthcare, PHC and Blockchain. Each interviewee was then “walked through” the 
contextual background of Blockchain-enabled PHC at the onset of each interview. Four typical 
health scenarios were selected by the research team in consultation with a domain expert as key 
business processes for PHC: registering a smart contract (enrolment); seeking clinical services 
(consultation); model building and validation (diagnostics); and performance monitoring of 
health outcomes (evaluation). 
 
It is salient that Vaishnavi and Kuechler (2015) referred to DSR as an improvement method. The 
essence of approaches such as SSM, DSR or agile is the improvement of a solution’s design. The 
SSM steps taken to develop such design artefacts are discussed in the following sections. More 
specifically, Section 4 delves deeper into our understanding of the problematic situation which 
includes “rich pictures” of key scenarios, and explores a “root definition” of a Blockchain 
solution. Section 5 describes the iterative refinement of design artefacts when put through design 
interviews with stakeholders and the exploration of a feasible solution. 
 
4. Problem specification of Blockchain-based PHC 
 
4.1 Problematic consideration 
 
The current challenge is that low opt-in rates and a lack of trust around genetic data sharing by 
patients leads to weak models and diagnostics. “Trustworthy” systems could reduce such 
concerns and increase patients’ willingness to participate in data sharing (Brodersen et al., 
2016). It is also known that there are significant ethical, legal and social implications of 
incorporating personalized medicine into healthcare. Brothers and Rothstein (2015) have 
analyzed the consequences of the significant increase in health information that will be brought 
about by personalized medicine and raise concerns about the potential of personalized medicine 
to exacerbate existing disparities in healthcare until and unless they are universal in scope and 
coverage. Therefore, our principal design postulate is that attributes of Blockchain such as 
transparency, traceability, tamper-proofing, immutability and compliance may mitigate against 
the current lack of trust in PHC services, especially with respect to the protection of genetic data, 
and bring about better cost and treatment outcomes. 
 
4.2 Issues expression (rich pictures) 
 
As described, SSM calls for hand-drawn illustrations as an aid to specify system requirements. In 
the case of the current context of PHC in New Zealand, Figure 3 shows such a “rich picture”. It 
was Checkland’s suggestion (cf. Checkland and Scholes, 1999) that such rich pictures provide a 
summary overview of the problematic solution as well as the iteratively enhanced solution. 
Typically, the SSM practitioner engages with system stakeholders to derive their “world views” 




Figure 3. Problem expression and world-views of stakeholders 
 
As previously mentioned, the healthcare eco-system of New Zealand was chosen for reasons of 
convenience as well as suitability. Currently in pilot stage, NZ’s PHC is based on a standard 
EHR architecture where every patient who opts-in is identifiable with his or her unique National 
Health Indicator (NHI). The benefits of an integrated, interoperable PHC-based EHR repository 
has yet to be introduced country-wide and each DHB operates its own “fire-walled” databases 
and models (Huang and Dobbie, 2017) using different standards, protocols and systems. Thus, 
data transactions are time-consuming and various security measures need to improve in order to 
deal with the redundancy of maintaining separate EHRs across DHBs. Moreover, the patients’ 
control over their own information is very limited (cf. Privacy-Commissioner, 2011). Research 
suggests that the rights of patients in granting data access privileges is a major contributor to 
their willingness to share their EHRs or EMRs (Patil and Seshadri, 2014; Kshetri, 2018). From a 
system level perspective, opting into PHCs could reduce time and costs for both patients and 
healthcare providers. For the patient, knowing possible health treatments and outcomes could be 
proactive preparation before a clinical visit (Shah et al., 2014). However, these benefits have not 
been sensed by key stakeholders. Besides ownership, patients’ concerns over information 
privacy and security in the PHC context are longstanding (Lunshof et al., 2008) and not easily 
overcome by assurances. Therefore, improved patient control of their health records and security 
appear to be key design challenges. 
 
 
Figure 4. SSM modelling and specification with rich-pictures 
 
Figure 3 illustrates the present ecosystem of PHC in New Zealand as derived by applying SSM. 
The annotation in red refers to the “problematic situation” from the perspective of key 
stakeholders that were obtained from the design interviews. The patient first visits a General 
Practitioner (GP) whenever he or she requires medical attention. By transcribing “health stories” 
onto the patient’s EHR, GPs primarily evaluate the patient’s health condition and either prescribe 
medication and treatment or, refer the patient to a hospital for advanced diagnostic tests, 
specialist care or admission. Within a DHB, the EHRs of the patient are accessible by health 
practitioners at the hospital. Since NZ is still in the process of implementing a country-wide 
health records database with NHIs as primary key, there are “islands of automation” with each 
DHB piloting its own PHC. A key assumption was made of the desirability of a country-wide 
PHC platform. 
 
During a “consultation”, “enrolled” patients who have opted-in to PHC pilot trials are asked for 
consent on sharing genome information for the benefit of precision medicine (e.g. treatments for 
cancer, heart diseases, diabetes, etc.). In some cases, the DHB may need to recruit the patient for 
genetic research. This, too, requires informed consent. After diagnosis, the test result(s) are sent 
to PHC service providers, along with redacted EHRs (ie non-PII data) but only their medical 
information. Currently, patients and their primary providers access PHC services for serious 
health conditions only. It was evident from our interviews that patients are not being informed 
about how their data is used for genetic sequencing models and predictive analytics, though such 
PII is more sensitive than other EHRs. Such types of uses often violate the transparency 
principles of Fair Information Practices (Teufel, 2008) which established principles for 
addressing privacy concerns, consistent with the data protection expectations of contemporary 
societies (Rubinstein, 2013). It is salient that user data in Blockchain are controlled with private 
and public encryption keys which give patients control over access rights to their EHRs + genetic 
sequences. 
 
For each of the four scenarios, “rich pictures” co-created, clarified, improved and refined during 
design interviews were means of obtaining a shared “worldview” as well as an understanding of 
a “problematic situation” for which design solutions could be formulated. Figure 4 shows rich 
pictures developed from interviews for two of the four scenarios – “consultation” (top) and 
“diagnostics” (bottom). Problematic issues with current PHC pilots are again annotated in red. It 
is clear that the protection of sensitive genome data requires a robust infrastructure with 
enhanced security. Discussing the four scenarios in sequence across interviews provided for a 
systems approach to problem modelling as well as solution specification. They were not static 
but, with successive interviews, dynamically evolved towards the design of a feasible solution. 
Prior to the formulation of a design solution, the “root definition” of “purposeful action” is more 
formally stated in Section 4.3. 
 
4.3 Root definition 
 
In SSM, the root definition is the first step towards developing a “purposeful system”. It 
comprises notations for the required specification that supports a verbal description. From a 
security standpoint, several field studies (e.g. Abouelmehdi et al., 2018) have shown that systems 
with a centralized architecture comprising data warehouses are more vulnerable to cyber-attacks, 
often resulting in data loss. Therefore, to improve the security features of a healthcare system, a 
distributed architecture could be feasible, whereby service providers would be able to replicate 
EHRs from hospitals within a DHB. This minimizes the risk of failure and other hazards derived 
from complicated data-intensive activities and processes (Xia and Song, 2012). Developing a 
Peer-to-Peer configuration (such as a Blockchain) to shorten the route of data flows is another 
workaround. Another key design feature is patients’ autonomy over their own genetic 
information and control over its use within a PHC eco-system. Hence, patients will be able to 
monitor the access, authorize and account for their EHRs in a transparent, traceable and tamper-
proof manner. Compliance through programmable SCs can be enforced as per legal provisions. 
They could also have oversight of data accesses, which should be immutable. In the absence of a 
TTP authority, Blockchain functionalities can audit the “actors” and their “activities” with each 
chain of transactions immutably recorded so as to clarify the accountability of legitimate actions 
(Caulfield et al., 2008). 
 
As a consequence of identifying the “problematic situation”, a programmable “informed 
consent” which may be implemented by the functionality of a “smart contract” was proposed as 
a design solution. With a smart contract, signing an informed consent should be the precondition 
to sharing patients’ EHRs + genetic information. In other words, it is an agreement between the 
patient and data accesses. Hence, all re-use of data will trigger execution of the SC. Each 
execution being transparently, traceably, tamper-evidently and immutably recorded to assure that 
patients’ data are used in accordance with the SC. Trust is enabled through the comprehensive 
tracking of data read, write, edit and delete operations and enhanced by validating such 
operations, either in real-time or batch audits, against the SCs. Hence, the role of SCs as key 
mechanisms which provide security and privacy to PHC emerged as a key requirement of a 
solution for the problematic situation. The next step in SSM is to explore key design 
functionalities of a Blockchain-enabled PHC. 
 
5. Solution design of Blockchain-based PHC 
 
The design of a solution and its validation is a check of whether the design artefacts are 
acceptable and useful for addressing the challenges identified (Peffers et al., 2007). In SSM, 
relevance is the key aspect of design validation (Checkland, 1995). It can be learned through 
listening to and analyzing stakeholders’ world-views about the problematic situation and 
proposed solution. Such an analysis entails both a reflection of issues in the real world and the 
values of stakeholders (Hanafizadeh and Mehrabioun, 2018). As design input was collected 
through several role-specific interviews across the healthcare eco-system, the generalization of 
world-views using procedures and techniques discussed in Section 3 is consistent with scholarly 
practices (Dorussen et al., 2005). The resulting solution is presented in this section. 
 
5.1 Analysis of models with real world 
 
In general, stakeholders interviewed showed similar concerns towards the adoption of PHC as 
the literature review had revealed; namely, the key attributes of security and privacy that could 
be addressed by Blockchain. Further, they understood why low opt-in rates result in weak and 
imprecise analytic modelling and hence treatments. This was seen as a logical consequence of 
concerns over trust in the protection of genetic and other health records. The weak data 
transparency and lack of controls of current PHC services were consistently mentioned across 
interviews. In short, the world-views of stakeholders converged on the link between trust and 
patients’ choice of opting-in to PHC. 
 
Using the CATWOE technique from SSM, which allows a high-level specification of a complex 
system’s “purposeful action” in terms of its key parameters, such a description of the PHC eco-
system is given in Table III. In the PHC eco-system, CATWOE allowed the first-cut 
identification and subsequent clarification of players, their roles and the values they create and 
capture. A key design feature of Blockchain-enabled PHC platforms is the notion of Smart 
Informed Consent by patients for access rights over their health records and genetic information 
(EHR+). Clients and actors could appreciate that these mechanisms would improve security and 
privacy in the practice of PHC. Moreover, the technical foundation of the SIC, comprising a 
programmable pre-approval of which actors could access patients’ EHRs + genetic sequences, 
was accepted. It was evident that the immutable tracking of distributed hyper-ledgers and 
tamper-proof Blockchains would enhance data transparency. Hence, security concerns could be 
reduced through the SIC-authorized, tamper-proof, RWED accesses to PHC data. A prototype 
SIC class diagram is beyond the scope of this study. However, in the exploratory design of an 
SIC solution, a more granular setting option which includes the RWED access type and time 
limit was constructed. Some default settings are necessary to implement the pre-emptive tracking 
of policy violations and compliance of service-level agreements. 
 
Table III. CATWOE of blockchain-enabled PHC 
Clients Patients 
Actors Patients, Providers, Vendors, Payers, Regulators – eco-system perspective 
Accessors, Participants, Miners – EHR perspective 
Transformation Educational Module in SIC before Patient enrolment 
Patient-Centered SIC compliant with Medico-Legal Policies 
Transparent, Traceable, Tamper-proof, Immutable EHR Flows for Compliance 
Auditing 
Hybrid Distributed Hyper Ledger: Blockchained SIC Integrated with Off-chained PII 
EHR Database 
Clear Metadata Established for the Separation of PII and aggregate models & data 
World View Improving Security and Privacy in order to Enhance Trust and Opt-in rates 
Raising the Knowledge Level of Patients about Security and Privacy Rights 
Eliciting Informed Consent for Patients’ opt-in and Access Control 
Reliable and Trusted Regulatory Monitoring 
Owner Health Ministry & DHBs (www.health.govt.nz/our-work/digital-health)  
Environment Governing Private, Permissioned (Consortium) Blockchain 
Constraints Legislation of Data Protection and Medical Ethics – Genetic Data abuse, Incentive 
Mechanisms, Emerging Technologies for 3TIC 
 
In such a participative, empathic manner, an improved “enrolment” process of SIC’s content 
structure was derived. A “design snapshot” is illustrated as a UML Activity Diagram in Figure 
5. Recall that this is the first of four scenarios being explored and serves as an example of how 
the other three scenarios were similarly discussed. From these iterations, caveats emerged, such 
as the need for a manual over-ride in exceptional cases (e.g. emergency situations where access 
was required by providers not pre-approved). The point being made is that design interviews 
traversed a level of complexity and fuzziness that were not as neat as the UML diagrams might 
suggest. 
 
Figure 5. Activity diagram for registering a smart contract (enrolment) 
 
 
Figure 6. Deployment diagram of authorization setting of SIC 
 
Figure 6 illustrates the SIC interface to clients (Patients) and Actors (Practitioners, 
Administrators, Vendors) and Figure 7 is a Use-Case Diagram of an SIC-enabled, Blockchain-
based PHC. Again, both were generated as design artefacts in a participative, iterative manner 
for the purpose of exploring, communicating and clarifying how the 3TIC design attributes of 
Blockchain could enable patients to exercise their rights to data security and privacy. In Figure 
6, each block contains the current hash value, the previous block’s hash value, time-stamp and 
application-execution records for RWED access. No records could be edited or deleted (unless 
explicitly allowed by the regulator), which guarantees the authenticity of each access 
transactions. The integrated ecosystem of SIC with PHC is illustrated as a Use-Case in Figure 
7, where patients have full access to their health + genetic data while other actors have different 
accessing authorization as per the set medical and legal restrictions. The SIC enforces 
compliance to such policies. 
 
 
Figure 7. Integrated use case diagram of PHC incorporating SIC 
 
A critical design consideration that emerged was the partititioning of PII and non-PII 
components of EHRs, expecially genetic information. Personally identifiable data and 
information are very sentitive aspects of the design of PHCs. Both the European Union 
(https://gdpr-info.eu/) and the United States (de facto – https://medium.com/golden-data/a-guide-
to-the-californiaconsumer-privacy-act-ccpa-3a916756ed36) have enacted laws that govern PII 
security and privacy service obligations. Hence, legal, medical and user requirements were for 
PII to be “off-chained” to the DHBs, providers, payers or patients. 
 
To illustrate further, the UML artefacts elicited much discussion about the design of adequate 
SIC controls over the setting of authorisations and access rights in the “enrolment” scenario. This 
corroborates Halim’s (2019) suggestion that: “To share aspects of their data, and to control who 
has the ability to search or contact them, individual users can simply adjust their permission 
settings using a so-called ‘dynamic consent platform’, a next-level access control mechanism for 
healthcare data. The more data there is, e.g. from electronic medical records, genomic data, 
streamed from wearables or other personal health records, the more need there is for data privacy 
and access control”. Addressing this aspect, several design ideas and inputs followed from the 
interviews, captured and refined with these diagrams. It was suggested and affirmed that in order 
to encourage patients to opt-in to PHC with effective incentive mechanisms, the fear of data 
sharing should be addressed through “strict, legally-enforcable” SIC controls. Such a shift in the 
world-view of patients is non-trivial. It should begin with education, defining how PHC could be 
a public good for the efficient and effective delivery of health services whose benefits accrue to 
all. 
 
Low adoption of Blockchain has been attributed to the lack of education and awareness of its 
capabilities (Clohessy and Acton, 2019). However, it is was recognized that education and 
appealing to altruism may not suffice to significantly increase “informed consent”. Considering 
the externality of healthcare services, an incentive scheme in the form of trust assurance could be 
effective in dissuading asymmetric opt-ins and free-riding. On the subject of security and 
privacy, several world-views pointed to the primary importance of the regulatory role in the 
ecosystem in order to enhance trust. The argument was raised that enforcement agencies should 
play a key role in the system to monitor the entire set of functionalities and processes. Regular 
traceable and tamper audits on SIC compliance must be transparently undertaken by trusted 
certificate authorities to ensure that PHC services function in compliance with prevailing 
policies. With reference to the back-end infrastructure of the PHC eco-system, there should be an 
integrated cloud storage for EHR + genetic sequences. This would be a logical progression to 
storing country-wide healthcare data on the hyper-ledger of Blockchain. 
 
Such an eco-system may not, as yet, be cost effective, considering the massive data and 
computational redundancy required in a Blockchain solution. Hence, it will be a great challenge 
for existing islands of EHRs to migrate to hyper-ledger platforms. Another design idea that 
emerged was the storing of EHRs “off-chain” in traditional databases while establishing pilots of 
Blockchain-based SICs as a good starting point. Such a workaround design would have the 
added benefit of protecting the EHR+ hyper-ledger by keeping the “key” and EHRs secure. 
Every use of the key could be monitored and RWED transactions would be immutable. 
Suspicious accesses would be flagged in real-time. 
 
5.2 Design changes and improvements 
 
Based on the design considerations that has emerged, we may logically reason that an effective 
SIC would reduce the security and privacy concerns of users. Specifically, with respect to the 
assurance of the “3TIC” design attributes in provisioning security and privacy for PHC. Hence 
the conceptual feasibility of our proposed solution was established. SSM is more amenable to 
theory exploration with conjectures such as principles and rules than theory construction with 
hypothesis. In that sense, the design principles and rules presented are postulates. In the 
nomenclature of design research, principles are over-arching considerations within which more 
specific, “how-to” rules may be specified. 
 
Figure 8 captures the fundamental theoretical findings of this exploratory design study in a 
summary manner. The cardinal design principle for PHC is that security and privacy is enhanced 
with such functionalities as the 3TIC design attributes of Blockchain. The distributed, 
decentralized and non-TTP characteristics of Blockchain allow patient-control of access and the 
off-chaining of PII. Following from this is the principle of confidence and trust which may be 
fulfilled by first educating stakeholders on the feasibility and limitations of such a solution, and 
next enforcing the monitoring and compliance of patient-approved SICs. Finally, the principle of 
demonstration will require that effective PHC outcomes such as lower costs and better treatment 
must be transparently monitored and validated by trusted authorities so as to promote further 
adoption. In a nutshell, the extent to which 3TIC design attributes of Blockchain are effectively 
implemented, leads to corresponding levels of security, privacy and trust. 
 
 
Figure 8. “Real-world” blockchain-based PHC solution 
 
The findings of this study were separately presented to officials of the Canterbury DHB and 
Callaghan Innovation (www.callaghaninnovation.govt.nz/ – part of the NZ government which 
funds the commercialization of research). The solution was accepted in principle as feasible. 
Commitment was secured from an NZ-based health informatics start-up enterprise and funding 
was approved by Callaghan to refine and commercialize the design of a Blockchain-enabled 
PHC service founded on the design principles presented in this research. The research has thus 
entered a proprietary, developmental phase that represents de facto industry validation of design 
artefacts (Vaishnavi and Kuechler, 2015). 
 
6. Discussion and implications 
 
This paper has derived using SSM a set of comprehensive and parsimonious design rules for a 
Blockchain-based PHC augmented with programmable SCs. As current PHC eco-systems are not 
capable of justifying how or when patients’ data or providers’ diagnosis will be utilized, PHC 
remains an untrusted service to the majority of its potential beneficiaries. This is attributable not 
only to the subjective perceptions of patients, but also the realization that current practices are 
unable to provide for adequate security and privacy. As our study revealed, fear of data abuse in 
legal proceedings, insurance matters and employment prospects also remain patients’ concerns. 
This finding corroborates prior research (cf. Abouelmehdi et al., 2018; Bruynseels et al., 
2018; Xia et al., 2017; Yue et al., 2016). Related research also corroborates that Blockchain 
could be developed to improve the security and privacy levels of trust-less PHC platforms 
(cf. Agbo et al., 2019; Park et al., 2019; Shuaib et al., 2019; Vazirani et al., 2019; Yaeger et al., 
2019). Security and privacy breaches are persistent and costly (Ponemon, 2016) and patients’ 
enrolment in PHC has not increased with its potential. As a consequence, the higher opt-in levels 
would improve the existing network effects and overall healthcare service level. 
 
Given current sensitivities surrounding “state-sponsored surveillance and technology-driven 
authoritarianism”, almost all the actors interviewed called for deep monitoring of PHC data, 
governance-assured by a designated authority (TTP?). This would be antithetical to the 
architecture of Blockchain platforms. Some key security policies should be set as laws and 
medical directives to regulate EHR+ usage and authorization in PHC eco-systems. It includes 
agreement on what constitutes meta-data, default data access setting, distinguishing RWED 
access authorization given to actors and access time limits. Finally, the ethics of incentivising 
opt-ins in order to discourage “free-riding” remained. Actors did not consider it to be socially 
acceptable that only clients who opted-in to PHC with their genetic sequences should be allowed 
the benefits of its predictive treatment and outcomes. 
 
 
Figure 9. Post implementation evaluation of design changes in SSM 
 
However, in order to be implemented in practice, further design refinements may be required in 
an agile, iterative manner. In his retrospective account of SSM, Checkland (2000) concedes that 
the methodology (as opposed to other design methods) was never intended to be academically 
rigorous but provide a systems thinking approach to action research that considers multiple 
perspectives and the macroreality of socio-political acceptance. In other words, the efficiency of 
design mattered less than its efficacy and SSM focusses on design exploration rather than theory 
construction. Based on Checkland’s (2000, p. S34) guidelines, Figure 9 suggests some 
recommendations that need to be addressed when seeking changes to the problematical situation. 
Whilst security and privacy are hygiene factors, there are other divers of adoption (Clohessy and 
Acton, 2019). 
 
Hence, we suggest several potentially fruitful avenues for future research. Using a PEST “world 
view”, researchers could consider Blockchain-based PHC from a cost-benefit point-of-view by 
comparing such systems with non-Blockchain alternatives. Some examples of costs include 
direct costs associated with implementing Blockchain-based PHC as well as costs associated 
with potential security and privacy breaches. Estimates suggest that the costs to enter and store 
data in Blockchain systems are significantly less than those associated with cloud services such 
as AWS (Reynoso, 2017). In addition to economic costs and benefits, it would be important to 
look at non-economic costs and benefits such as the social costs of not sharing full health records 
with a PHC eco-system and psychological benefits associated with patients’ confidence in the 
diagnostics of Blockchain-based PHC. The design of dashboards, benchmarking and prescriptive 
analytics are also worthy of research. 
 
One limitation of this research was its scope that was limited to the modelling of New Zealand’s 
healthcare ecosystem. As an emerging technology, use-cases of Blockchain in other domains of 
high impact (e.g. public services and food safety) would be important contributions to 
knowledge. Thus, this paper is positioned as an exploratory study to investigate Blockchain and 
its application in a significant context such as PHC. The issue of scalability has been noted as a 
major limitation of Blockchain applications (Shuaib et al., 2019). The carbon footprint 
associated with large volumes of duplicate data and ensuing latency are symptoms of the 
inherent functionalities of the technology. Smart Contracts for off-chaining, partitioned and 
hybrid blockchains could be further specified to address the performance required by PHC. It 
would be contentious to explore if an incentive mechanism could be applied in a form like 
granting PHC coins (a crypto-currency that rewards data contributions that may be used as 
credits for PHC services) to increase the opt-in rates of patients. 
 
Another area concerns a comparison of Blockchain-based PHC with current big data-based 
applications favoured by Managed Health-Care Organisations in terms of externalities and a 
“tragedy of the commons”. For instance, it is argued that traditional big data-based applications 
allow scientists to use such data in research and improve human well-being. Huge volumes of 
patient data help detect drug interactions as well as design drug therapies. Some state and federal 
health information exchanges provide information on individual patients, which can contribute to 
effective drug regulation and cost reductions. They may also reduce indirect costs associated 
with lower precision (Zimmerman, 2019). Further research could examine how Blockchain-
enabled PHC may potentially transform these sources of externalities, by shifting the locus of 
control from the institution providing healthcare to health consumerism from patients (Kshetri, 
2018). 
 
Finally, further research on the applications of emerging technologies in PHC could also 
investigate the development of PHC portfolios which “sense” patients’ healthcare data from IoT 
and wearable devices, analyse them with genetic information and improve with powerful 
machine learning models[2]. If PHC opt-in rates increase with the incorporation of Blockchain 
and augmented technologies, the concept of a Digital Twin (Bruynseels et al., 2018) could be a 
disruption in personalized healthcare equivalent to 3D printing in manufacturing. However, no 
matter the good intentions, the entry of genetic sequences into health treatments and outcomes 
must proceed with deep ethical reflection (Brothers and Rothstein, 2015). A critique of “good 
practices” across industry players and government policies would shed insights on the challenges 
and pitfalls of implementing EHR+PHC. 
 
In closing, the research reported in this paper suggests that while there remain significant 
implementation issues for effective Blockchain-enhanced PHC, it is worthy of further research. 
We conjecture that the decentralized and distributed nature of Blockchain is congruent with the 
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